Cargando…

The efficacy and safety of acupuncture in nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials

BACKGROUND: The aim of this study was to determine the efficacy and safety of acupuncture treatment (AT) or acupuncture plus conventional medicine (CM) versus CM alone using a meta-analysis of all published randomized controlled trials (RCTs) for nonalcoholic fatty liver disease (NAFLD). METHODS: Ei...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Peiwen, Zhong, Xin, Dai, Yunkai, Tan, Meiao, Zhang, Gaochuan, Ke, Xuehong, Huang, Keer, Zhou, Zunming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462626/
https://www.ncbi.nlm.nih.gov/pubmed/34559098
http://dx.doi.org/10.1097/MD.0000000000027050
_version_ 1784572237824655360
author Chen, Peiwen
Zhong, Xin
Dai, Yunkai
Tan, Meiao
Zhang, Gaochuan
Ke, Xuehong
Huang, Keer
Zhou, Zunming
author_facet Chen, Peiwen
Zhong, Xin
Dai, Yunkai
Tan, Meiao
Zhang, Gaochuan
Ke, Xuehong
Huang, Keer
Zhou, Zunming
author_sort Chen, Peiwen
collection PubMed
description BACKGROUND: The aim of this study was to determine the efficacy and safety of acupuncture treatment (AT) or acupuncture plus conventional medicine (CM) versus CM alone using a meta-analysis of all published randomized controlled trials (RCTs) for nonalcoholic fatty liver disease (NAFLD). METHODS: Eight databases were searched independently from inception to April 30, 2020. RCTs were included if they contained reports on the use acupuncture or the use of acupuncture combined with CM and compared with the use of CM. Summary odds ratio (OR) and 95% confidence intervals (CIs) were used to calculate the overall clinical efficacy. Secondary outcomes, namely aspartate aminotransferase, alanine aminotransferase, total cholesterol, triglyceride, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and body mass index, were calculated by mean difference with 95% CIs. RESULTS: After the final screening, 8 RCTs with 939 patients were included. This meta-analysis showed that AT was superior to CM in improving overall clinical efficacy (OR = 3.19, 95% CI: 2.06–4.92, P < .00001). In addition, AT plus CM could significantly improve overall clinical efficacy compared to treatment with CM alone (OR = 5.11, 95% CI: 2.43–10.75, P < .0001). Moreover, the benefits were also demonstrated in other outcomes, including alanine aminotransferase, aspartate aminotransferase, total cholesterol, triglyceride, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol indexes. However, AT plus CM could not decrease body mass index levels in comparison with CM. The safety profile of Acupuncture therapy was satisfactory. Taichong, Zusanli, Fenglong, and Sanyinjiao were major acupoints on NAFLD treatment. CONCLUSION: Acupuncture may be effective and safe for treatment of NAFLD. However, due to insufficient methodological quality and sample size, further high-quality studies are needed.
format Online
Article
Text
id pubmed-8462626
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-84626262021-09-27 The efficacy and safety of acupuncture in nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials Chen, Peiwen Zhong, Xin Dai, Yunkai Tan, Meiao Zhang, Gaochuan Ke, Xuehong Huang, Keer Zhou, Zunming Medicine (Baltimore) 3800 BACKGROUND: The aim of this study was to determine the efficacy and safety of acupuncture treatment (AT) or acupuncture plus conventional medicine (CM) versus CM alone using a meta-analysis of all published randomized controlled trials (RCTs) for nonalcoholic fatty liver disease (NAFLD). METHODS: Eight databases were searched independently from inception to April 30, 2020. RCTs were included if they contained reports on the use acupuncture or the use of acupuncture combined with CM and compared with the use of CM. Summary odds ratio (OR) and 95% confidence intervals (CIs) were used to calculate the overall clinical efficacy. Secondary outcomes, namely aspartate aminotransferase, alanine aminotransferase, total cholesterol, triglyceride, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and body mass index, were calculated by mean difference with 95% CIs. RESULTS: After the final screening, 8 RCTs with 939 patients were included. This meta-analysis showed that AT was superior to CM in improving overall clinical efficacy (OR = 3.19, 95% CI: 2.06–4.92, P < .00001). In addition, AT plus CM could significantly improve overall clinical efficacy compared to treatment with CM alone (OR = 5.11, 95% CI: 2.43–10.75, P < .0001). Moreover, the benefits were also demonstrated in other outcomes, including alanine aminotransferase, aspartate aminotransferase, total cholesterol, triglyceride, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol indexes. However, AT plus CM could not decrease body mass index levels in comparison with CM. The safety profile of Acupuncture therapy was satisfactory. Taichong, Zusanli, Fenglong, and Sanyinjiao were major acupoints on NAFLD treatment. CONCLUSION: Acupuncture may be effective and safe for treatment of NAFLD. However, due to insufficient methodological quality and sample size, further high-quality studies are needed. Lippincott Williams & Wilkins 2021-09-24 /pmc/articles/PMC8462626/ /pubmed/34559098 http://dx.doi.org/10.1097/MD.0000000000027050 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle 3800
Chen, Peiwen
Zhong, Xin
Dai, Yunkai
Tan, Meiao
Zhang, Gaochuan
Ke, Xuehong
Huang, Keer
Zhou, Zunming
The efficacy and safety of acupuncture in nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials
title The efficacy and safety of acupuncture in nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials
title_full The efficacy and safety of acupuncture in nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials
title_fullStr The efficacy and safety of acupuncture in nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials
title_full_unstemmed The efficacy and safety of acupuncture in nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials
title_short The efficacy and safety of acupuncture in nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials
title_sort efficacy and safety of acupuncture in nonalcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials
topic 3800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462626/
https://www.ncbi.nlm.nih.gov/pubmed/34559098
http://dx.doi.org/10.1097/MD.0000000000027050
work_keys_str_mv AT chenpeiwen theefficacyandsafetyofacupunctureinnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT zhongxin theefficacyandsafetyofacupunctureinnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT daiyunkai theefficacyandsafetyofacupunctureinnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT tanmeiao theefficacyandsafetyofacupunctureinnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT zhanggaochuan theefficacyandsafetyofacupunctureinnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT kexuehong theefficacyandsafetyofacupunctureinnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT huangkeer theefficacyandsafetyofacupunctureinnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT zhouzunming theefficacyandsafetyofacupunctureinnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT chenpeiwen efficacyandsafetyofacupunctureinnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT zhongxin efficacyandsafetyofacupunctureinnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT daiyunkai efficacyandsafetyofacupunctureinnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT tanmeiao efficacyandsafetyofacupunctureinnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT zhanggaochuan efficacyandsafetyofacupunctureinnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT kexuehong efficacyandsafetyofacupunctureinnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT huangkeer efficacyandsafetyofacupunctureinnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT zhouzunming efficacyandsafetyofacupunctureinnonalcoholicfattyliverdiseaseasystematicreviewandmetaanalysisofrandomizedcontrolledtrials